{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"Target enrollment (n=20) was not reached. The study was stopped during the interim analysis due to low accrual after the widespread use of plerixafor for multiple myeloma in the United States."},"pointOfContact":{"email":"amit.verma@einsteinmed.edu","organization":"Albert Einstein College of Medicine","phone":"718-430-4091","title":"Dr. Amit Verma"}}